![](https://www.massdevice.com/wp-content/uploads/2025/02/JNJ-Cerenovus-EMBOTRAP-3-blood-clot-close-up.jpg)
Johnson & Johnson reportedly wants to sell its Cerenovus stroke business for $1B
Jim Hammerand is the managing editor of Medical Design & Outsourcing. He has more than two decades of journalism experience spanning newspapers, magazines, websites, live events, radio and TV news. For nearly a decade, Hammerand reported and edited …